V
Vivos Therapeutics, Inc. (VVOS)
NCM – Real vaqt narxi. Valyuta: USD
0.73
+0.03 (4.85%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.74
+0.01 (1.79%)
Bozor oldidan: May 13, 2026, 8:06 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.73
+0.03 (4.85%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.74
+0.01 (1.79%)
Bozor oldidan: May 13, 2026, 8:06 AM EDT
Vivos Therapeutics, Inc. tibbiy texnologiyalar kompaniyasi sifatida faoliyat yuritadi, u dentofasiyal anomaliyalar, obstruktiv uyqu apnesi (OSA) va kattalardagi xurrak bilan og'rigan bemorlarni davolash usullarini ishlab chiqadi va tijoratlashtiradi. Kompaniya dentofasiyal anomaliyalar, OSA va xurrakni davolash uchun invaziv bo'lmagan, jarrohliksiz, farmatsevtikasiz, ko'p tarmoqli davolash usuli bo'lgan Vivos Methodni taklif etadi. Kompaniya, shuningdek, kattalar va bolalar uchun skrining va uyquni uyda tekshirish bo'lgan VivoScore dasturini taklif etadi. U o'z qurilmalarini va tegishli davolash usullari va xizmatlarini asosan Qo'shma Shtatlar va Kanadadagi litsenziyalangan mutaxassislarga, birinchi navbatda umumiy stomatologlarga sotadi. Kompaniya ilgari Vivos BioTechnologies, Inc. nomi bilan tanilgan va 2018-yil mart oyida Vivos Therapeutics, Inc. nomini o'zgartirgan. Kompaniya 2016-yilda tashkil etilgan va Kolorado shtatining Litlton shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Terry Jones | Senior VP of Human Resources |
| Jennifer Hauser | Executive Assistant to CEO and Chairman & CFO |
| Mr. Bradford K. Amman | CFO, Treasurer & Secretary |
| Mr. Michael E. Bruhn | Executive VP of Business Operations Integration |
| Mr. Nicholas M. DeGennaro | Senior Vice President of Mergers and Acquisition Group |
| Mr. R. Kirk Huntsman | Co-Founder, Chairman of the Board & CEO |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-22 | 8-K | form8-k.htm |
| 2026-04-15 | 8-K | form8-k.htm |
| 2026-04-03 | 8-K | form8-k.htm |
| 2026-03-31 | NT 10-K | formnt10-k.htm |
| 2026-02-17 | S-3 | forms-3.htm |
| 2026-02-06 | 8-K | form8-k.htm |
| 2026-01-20 | 8-K | form8-k.htm |
| 2026-01-16 | 8-K | form8-k.htm |
| 2026-01-02 | POS AM | formposam.htm |
| 2025-12-17 | 8-K | form8-k.htm |
| Mr. Todd Huntsman | Co-Founder & Senior VP of Product and Technology |
| Ms. RaeAnn Byrnes | Co-Founder and Senior VP of Events & Clinical Advisory Services |
| Ms. Susan McCullough | Co-Founder & Executive VP of Operations |